Geespace Accelerates Global Expansion as GEESATCOM Enters New Markets 
KEF, the premium speaker brand of Gold Peak, partners with Huawei to unlock new wireless high-fidelity experience with HUAWEI HiPlay 
CBL International Limited Wins Prestigious ‘CGMA Excellent Sustainability Award’ at the CGMA Annual Awards 2025 
Fab-Form Industries Ltd. Announces Results for the Quarter Ended 30 September 2025 
Aires Announces Record Q3/2025 Revenue of $7.4 Million and 61% YoY Sales Growth and Discusses Factors Related to Liquidity and Continuing Operations Oyster Point Pharma to Present at Upcoming Investor Conferences in January 2022
PRINCETON, N.J., Dec. 21, 2021 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a…
Sanofi: Information concerning the total number of voting rights and shares – NOVEMBER 2021
Information concerning the total number of voting rights and shares, provided pursuant to article L….
Valneva Announces Positive Lot-to-Lot Consistency Trial Results for its Single-Shot Chikungunya Vaccine Candidate
Saint Herblain (France), December 21, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a…
Tauriga Sciences Inc. Receives Product Endorsement From the State of Alaska
Endorsement Applies to: Tauri-Gum™ Product Line New York, NY, Dec. 21, 2021 (GLOBE NEWSWIRE) —…
OSE Immunotherapeutics Strengthens Leadership Team with the Appointment of Laurence de Schoulepnikoff as Chief Business Officer
In Addition, Three Senior Executives Will Reinforce the Company’s Drug Development Engine NANTES, France, Dec….
RAFA Enters into Negotiations with JINR for Ultra-Cutting Edge Nuclear Research
Nicosia, Cyprus, Dec. 21, 2021 (GLOBE NEWSWIRE) — Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is currently negotiating…
Intrommune Therapeutics Names Sergi X. Trilla, MD, MBA as its Director, Corporate Strategy & Partnerships
Dr. Trilla’s 30-Year Career as a Life Science and Business Entrepreneur Provides Unique Value to…
Science Journal Finds No Evidence to Support Claims of Data Manipulation in 2005 Publication
Editor-in-Chief States: “After Careful Examination of These Original Material, Neuroscience [Journal] Found No Evidence of…
Bioventus Appoints Michelle McMurry-Heath to Board of Directors
Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO) Michelle McMurry-Heath Joins Bioventus…
CDC Publishes AXIM® Biotechnologies-Sponsored Study on COVID-19 Neutralizing Antibodies
SAN DIEGO, Dec. 21, 2021 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,”…
Syneos Health Releases 2022 Health Trends
New Era of Biopharma Product Development to be Fueled by Value Creation, Human Centricity and…
Rakovina Therapeutics Announces Non-dilutive Financial Contributions to Support Lead Optimization of Novel Anti-cancer Agents
VANCOUVER, British Columbia, Dec. 21, 2021 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSXV: RKV) (“the…
Fortress Biotech to Ring Nasdaq Stock Market Closing Bell on December 21
NEW YORK, Dec. 21, 2021 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an…
Pliant Therapeutics to Participate in the 40th Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
ExCellThera announces settlement of its patent infringement claims against Selleck Chemicals
MONTRÉAL, Dec. 21, 2021 (GLOBE NEWSWIRE) — ExCellThera Inc., a clinical-stage cell expansion and engineering…
Certara Announces FDA Renewal and Expansion of Certara’s Biosimulation Software for Reviewing Regulatory Submissions
FDA holds more than 400 Simcyp™ and Phoenix™ software licenses across 12 divisions and offices…
Zogenix Submits New Drug Application for FINTEPLA® (Fenfluramine) in Japan for the Treatment of Epileptic Seizures Associated with Dravet Syndrome
EMERYVILLE, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) — Zogenix, a global biopharmaceutical company specializing in…
Achilles Therapeutics to present at the 40th Annual J.P. Morgan Healthcare Conference
LONDON, Dec. 21, 2021 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical…
First U.S. patients with persistent cardiac arrythmias treated using Volta Medical’s artificial intelligence-based analysis
Novel, FDA-cleared and CE-certified medical device is designed to help cardiologists identify cardiac abnormalities in…
Hepion Pharmaceuticals Announces FDA Clearance of IND Application for CRV431 in the Treatment of Liver Cancer
– New IND Expands Liver Disease Pipeline for CRV431 – – IND Clearance Allows CRV431…